Skip to main content

previous disabled Page of 3
and
  1. No Access

    Article

    What is new in the 5th edition of the World Health Organization classification of mature B and T/NK cell tumors and stromal neoplasms?

    The classification of tumors is essential in the diagnosis and clinical management of patients with malignant neoplasms. The World Health Organization (WHO) provides a globally applicable classification scheme...

    Ayoma D. Attygalle, John K. C. Chan, Sarah E. Coupland in Journal of Hematopathology (2024)

  2. No Access

    Article

    Molekulare Diagnostik des vitreoretinalen Lymphoms

    Das primäre vitreoretinale Lymphom (PVRL) stellt einen Subtyp der intraokularen Lymphome bzw. der malignen Lymphome des Auges dar. Das PVRL gilt als Sonderform des primären diffusen großzelligen Lymphoms (DLBC...

    PD Dr. rer. nat. Irina Bonzheim, Julia Salmerón-Villalobos in Die Pathologie (2023)

  3. Article

    Open Access

    Resistance to immune checkpoint therapies by tumour-induced T-cell desertification and exclusion: key mechanisms, prognostication and new therapeutic opportunities

    Immune checkpoint therapies (ICT) can reinvigorate the effector functions of anti-tumour T cells, improving cancer patient outcomes. Anti-tumour T cells are initially formed during their first contact (priming...

    Mona Meng Wang, Sarah E. Coupland, Tero Aittokallio in British Journal of Cancer (2023)

  4. Article

    Open Access

    Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748

    Rita Alaggio, Catalina Amador, Ioannis Anagnostopoulos, Ayoma D. Attygalle in Leukemia (2023)

  5. Article

    Open Access

    SF3B1 hotspot mutations confer sensitivity to PARP inhibition by eliciting a defective replication stress response

    SF3B1 hotspot mutations are associated with a poor prognosis in several tumor types and lead to global disruption of canonical splicing. Through synthetic lethal drug screens, we identify that SF3B1 mutant (SF3B1

    Philip Bland, Harry Saville, Patty T. Wai, Lucinda Curnow in Nature Genetics (2023)

  6. Article

    Open Access

    Patient-derived zebrafish xenografts of uveal melanoma reveal ferroptosis as a drug target

    Uveal melanoma (UM) has a high risk to progress to metastatic disease with a median survival of 3.9 months after metastases detection, as metastatic UM responds poorly to conventional and targeted chemotherapy...

    Arwin Groenewoud, Jie Yin, Maria Chiara Gelmi, Samar Alsafadi in Cell Death Discovery (2023)

  7. No Access

    Article

    Ruthenium106 plaque brachytherapy for uveal leiomyoma: a new approach to treatment?

    Katharina Eibenberger, Rumana Hussain, Yamini Krishna, Sarah E. Coupland in Eye (2023)

  8. Article

    Open Access

    Conjunctival Lymphoma

    Lymphoma of the conjunctiva is an ocular malignancy derived from clonal proliferation of lymphocytes. The majority of conjunctival lymphoma is extranodal marginal zone B-Cell lymphoma (EMZL), however diffuse l...

    Lindsay A. McGrath, David A. Ryan, Sunil K. Warrier, Sarah E. Coupland in Eye (2023)

  9. Article

    Open Access

    The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms

    The upcoming 5th edition of the World Health Organization (WHO) Classification of Haematolymphoid Tumours is part of an effort to hierarchically catalogue human cancers arising in various organ systems within ...

    Joseph D. Khoury, Eric Solary, Oussama Abla, Yassmine Akkari, Rita Alaggio in Leukemia (2022)

  10. Article

    Open Access

    The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

    We herein present an overview of the upcoming 5th edition of the World Health Organization Classification of Haematolymphoid Tumours focussing on lymphoid neoplasms. Myeloid and histiocytic neoplasms will be pres...

    Rita Alaggio, Catalina Amador, Ioannis Anagnostopoulos, Ayoma D. Attygalle in Leukemia (2022)

  11. No Access

    Chapter

    Develo** Prognostic Tools for Estimating Risk of Metastatic Death and Non-Metastatic Death in Individuals with Choroidal Melanoma

    Approximately 50% of all patients with choroidal melanoma develop metastatic disease after months or years of apparent good health following ocular treatment. We have developed mathematical models to estimate ...

    Bertil E. Damato, Antonio Eleuteri in Global Perspectives in Ocular Oncology (2022)

  12. No Access

    Chapter

    Application of Deep Learning Models in the Evaluation of Histopathology of Uveal Melanoma

    Digital pathology is being increasingly implemented in basic and translational research, as well as in routine clinical care for diagnostics and prognostication. With the latter, it is essentially an additiona...

    Sarah E. Coupland, Hongrun Zhang, Hayley Jones in Global Perspectives in Ocular Oncology (2022)

  13. No Access

    Chapter

    Intraocular Lymphomas

    Lymphoma is a malignant neoplasm derived from monoclonal proliferations of B- or T-lymphocytes and rarely, natural killer (NK) cells. Ophthalmic involvement is relatively rare and may involve the ocular adnexa...

    Kaustubh Mulay, Santosh G. Honavar, Santosh U. Kafle in Intraocular Tumors (2020)

  14. No Access

    Chapter

    Genetics of Uveal Melanoma

    Uveal melanoma is a rare, aggressive intraocular malignant tumor, leading to metastatic disease in over 50% of patients with tumors located in the ciliary body or choroid. Genetic studies have identified chrom...

    Helen Kalirai, Alexander Iu. Tsygankov, Sophie Thornton in Intraocular Tumors (2020)

  15. Article

    Open Access

    CM-Path Molecular Diagnostics Forum—consensus statement on the development and implementation of molecular diagnostic tests in the United Kingdom

    Pathology has evolved from a purely morphological description of cellular alterations in disease to our current ability to interrogate tissues with multiple ‘omics’ technologies. By utilising these techniques ...

    Philip S. Macklin, Nischalan Pillay, Jessica L. Lee in British Journal of Cancer (2019)

  16. No Access

    Chapter

    Classification of Uveal Tumors

    Tumors of the same class should share a unique combination of features, which distinguishes them from all other classes. Classification, therefore, is the process of defining different tumor classes and correl...

    Bertil E. Damato, Sarah E. Coupland in Clinical Ophthalmic Oncology (2019)

  17. No Access

    Chapter

    Diagnostic Techniques: Other Biopsy Techniques

    Alternatives to fine-needle aspiration biopsy include vitreous cutter aspiration biopsy, incisional biopsy, and excisional biopsy. Vitreous cutter aspiration biopsy is performed with a 25- or 27-gauge vitreous...

    Bertil E. Damato, Armin Afshar, Sarah E. Coupland in Clinical Ophthalmic Oncology (2019)

  18. No Access

    Chapter

    Uveal Melanoma: Molecular Pathology

    Research into the molecular genetics of uveal melanomas (UM) has identified several predictors of metastatic disease as well as signaling pathways and molecules that can be targeted using systemic therapies. M...

    Sarah E. Coupland, Helen Kalirai, Sophie Thornton in Clinical Ophthalmic Oncology (2019)

  19. No Access

    Chapter

    Uveal Melanoma: Prognostication Methods

    Almost 50% of uveal melanoma (UM) patients develop metastatic disease, despite successful ocular treatment. Metastases usually involve the liver and only rarely respond to treatment so that most patients die w...

    Sarah E. Coupland, Azzam Taktak, Antonio Eleuteri in Clinical Ophthalmic Oncology (2019)

  20. No Access

    Chapter

    Uveal Lymphoproliferative Tumors

    Lymphoid proliferations of the uvea can be divided into two main groups: (a) primary uveal tumors and (b) secondary intraocular manifestations of systemic lymphoma. Although the exact frequency of the latter i...

    Sarah E. Coupland, Arun D. Singh in Clinical Ophthalmic Oncology (2019)

previous disabled Page of 3